Research Report on Gymnema GS4™
Gymnema GS4® and GS4 PLUS® are proprietary extracts of Gymnema sylvestre, standardized to contain 25% and 75% gymnemic acids, respectively, developed by Sabinsa Corporation.
These extracts have been the subject of various scientific studies, particularly concerning their potential benefits in blood sugar regulation and diabetes management.
Clinical Research and Findings:
- Blood Sugar Regulation:Becarre Natural
- Diabetes Management:SelfDecode Supplements
- Mechanism of Action:Anabolic Minds
Safety and Dosage:
Studies have confirmed the safety of GS4 PLUS® even with long-term use. However, it's essential to consult with a healthcare professional before starting any new supplement, especially for individuals with underlying health conditions or those taking other medications.
Conclusion:
The proprietary extracts GS4® and GS4 PLUS® by Sabinsa have been extensively studied for their potential benefits in blood sugar regulation and diabetes management. The active components, gymnemic acids, play a significant role in these effects. While research supports their efficacy, individual results may vary, and professional medical advice is recommended before use.
To summarize the key data points from the studies mentioned, such as:
- The effect of Gymnema sylvestre on blood sugar levels.
- Its impact on HbA1c (glycated hemoglobin).
- Possible insulin usage reduction.
- Regeneration of islet cells in experimental studies.
See below charts for hypothetical graphs based on typical research outcomes in these areas.
GS4® and GS4 PLUS®:
- Blood Sugar Levels Over Time: Shows a gradual reduction in blood sugar for the treatment group compared to a placebo group.
- HbA1c Levels Before and After Treatment: Demonstrates a significant decrease in HbA1c levels for the treatment group, indicating improved long-term blood sugar control.
- Insulin Usage Reduction Over Time: Illustrates the treatment group requiring less insulin over 30 days compared to a constant usage in the placebo group.
Research on Gymnema GS4® and GS4 PLUS®, proprietary extracts of Gymnema sylvestre developed by Sabinsa Corporation, has been conducted by various researchers. Notable studies and their authors include:
- Baskaran, K., Kizar, A. B., & Shanmugasundaram, K. R. (1990).
- Shanmugasundaram, E. R. B., Rajeswari, G., Baskaran, K., Rajesh Kumar, B. R., Radha Shanmugasundaram, K., & Kizar, A. B. (1990).
- Devangan, S., Varghese, B., Johny, E., Gurram, S., & Adela, R. (2021).
- Shanmugasundaram, E. R. B., Gopinath, K. L., Radha Shanmugasundaram, K., & Rajendran, V. M. (1990).
These studies have contributed to understanding the potential benefits of Gymnema sylvestre extracts in diabetes management.